Healthcare News - An Overview
FTC sues major pharmacy profit administrators about insulin rates The agency brought action against Caremark, Categorical Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating techniques “artificially inflated” the listing price of existence-preserving insulin medicine.Pay attention to the report ten min This audio is c